Skip to main content
. 2017 Mar 1;8(4):542–548. doi: 10.1002/jcsm.12193

Table 4.

Comparison of laboratory findings between patients with and without muscle wasting, n = 55

Characteristics Muscle wasting P value
Yes n = 26 No n = 29
NT‐pro BNP (ng/dL), median (IQR) 836 (139–2400) 833 (100–1462) 0.5
6‐MWT distance (metre) 338 (140) 440 (124.5) 0.01
Haemoglobin (g/L) 13.8 (2) 13.8 (1.9) 0.8
Serum total protein (g/L) 71 (7.1) 69 (5.1) 0.3
Serum albumin (g/L) 43.1 (5.1) 43.2 (4.9) 0.9
BUN (mg/dL) 20.2 (6.7) 17.7 (5.8) 0.1
Creatinine (mg/dL) 0.8 (0.2) 0.9 (0.17) 0.5
Sodium (mmol/L) 136 (4.6) 138 (3.9) 0.1
Potassium (mmol/L) 4.2 (0.4) 4.2 (0.4) 0.6
Triglyceride (mg/dL) 140.5 (91.3) 167.6 (83.2) 0.4
Cholesterol (mg/dL) 156.8 (66) 191.6 (42.6) 0.1
LDL (mg/dL) 95.5 (44.7) 107.3 (28) 0.4
HDL (mg/dL) 38.1 (5.4) 42.5 (14) 0.3
Vitamin D3 level (ng/mL) 16.1(11.7) 22.4 (18.5) 0.1
Osteopenia in BMD, number (%) 10 (38.5) 11 (37.9) 0.9
ASM/height ratio (kg/m2) 5993.2 (976.3) 7089 (819.7) 0.0001

6MWT, 6‐min walk test; ASM, appendicular muscle mass; BMD, bone mass densitometry; BUN, blood urea nitrogen; HDL, high density lipoprotein; LDL, low density lipoprotein; NT‐pro BNP, N‐terminal pro brain natriuretic peptide.